NPPA brings down prices of anti cancer drugs upto 85%
Government of India has brought 42 non-scheduled anti-cancer drugs under price control, capping trade margin at 30 per cent, which would reduce their retail prices […]
Month: March 2019
Strides receives USFDA approval for Ethosuximide Softgel capsules
Strides Pharma Science through its subsidiary has received USFDA approval for Ethosuximide Softgel capsules prescribed as an anti-epileptic medication. The drug is a generic version […]
USFDA promotes generic medicines
USFDA is allaying fears of generic medicine to provide a boost to Indian pharmaceutical sector. Apparently, over 90% of United States drug market is dominated […]
Sanofi receives USFDA approval for Calibri
Sanofi India has received USFDA approval for its drug Calbivi which is tested to treat a rare blood-clotting disorder in adults in combination with standard-of-care […]
Alembic receives USFDA approval for Acetazolamide
Alembic Pharmaceuticals has received final USFDA approval for Acetazolamide extended-release capsules, used for the treatment of various kinds of glaucoma. The drug is therapeutically equivalent […]
Glenmark Pharma receives USFDA approval for Sevelamer Hydrochloride
Glenmark Pharma has received final USFDA approval for Sevelamer Hydrochloride tablets to market the same in US markets. The product is prescribe for controlling serum […]
Wockhardt receives USFDA approval for generic prostrate cancer tablet abiraterone acetate
Wockhardt has received final USFDA approval for its generic prostrate cancer tablet abiraterone acetate. The drug in strength of 250mg is a generic version of […]
Strides Pharma Science receives USFDA approval for Triamcinolone Acetonide
Strides Pharma Science (Strides) through Strides Pharma Global, Singapore has received USFDA approval for its drug Triamcinolone Acetonide to market the same in US markets. […]